Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2020-10-19
2021-09-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Three Basic Progressive Lens Designs
NCT05252871
Clinical Assessment of a Customized Free-form Progressive Addition Lens Spectacle
NCT01234207
Quality of Life in Presbyopes Using Single-vision Lens and Progressive Lens Correction
NCT06699784
Non-comparative Study to Assess the Visual Performances and Safety of a Progressive Multifocal Intraocular Lens
NCT02838004
Study of Presbyopia-correcting Intraocular Lenses in Eyes With Previous Corneal Refractive Surgery
NCT04522427
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Nowadays many different types of progressive addition lenses are available for the correction of presbyopia. Progressive addition lenses provide a more natural correction for presbyopic people due to a gradual and progressive increase of lens power from far area through the intermediate portion to the near area. However, some patients still experience adaptation problems.
The primary purpose of the study is to evaluate the preference, adaptability and visual performance of progressive lens designs (up to three designs).
Study procedures:
Each participant is required to wear all pairs of spectacles one after another, each pair for one week.
Each participant will be required to visit the optometry clinic (at University of Milano Bicocca) three times:
Visit #1: Screening based on inclusion criteria, Informed Consent Form (ICF) form signing, Optometric exam and choice of the frame.
Subjects who will pass the inclusion/exclusion screening will be asked to sign the ICF and enrolled for the optometric exam. Subjects will choose the spectacle frame and all individual fitting parameters will be measured for lens' manufacturing.
Visit #2: Subjects will receive three marked pairs of progressive lenses. The three spectacle frames will be adjusted to fit properly on the subject' face. After 10-15 min of wearing of the first pair of lenses, each subject will be asked to answer to a questionnaire.
Visit #3 (last visit): questionnaires should be returned; the last comparison question will be answered during this visit, and subject will choose the best pair.
At the end of the study each participant will be entitled to get one pair of progressive lenses available in the market.
Subject population:
Presbyopic subjects have been already wearing any progressive additional lens (PAL) designs.
Number of Subjects:
40 +/- 2 subjects, the specified PAL design wearers and 40 +/- 2 the other PAL design wearers to be enrolled and signed the informed consent form.
Each subject will be wearing three different PAL designs. Subjects will be asked to choose one pair of spectacles (design) which they like the most.
Randomisation:
This study adopts a stratified permuted block randomisation to reduce an evaluation bias by the wearing sequence and prescriptions. The mean of both eyes' prescriptions is set as a single stratification factor.
Frames:
Each subject will choose a model of spectacle frame. Three identical frames will be taken for each subject.
Lenses:
1. Lenses will be produced in EU
2. Three different lens designs will be tested in the study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
The specified PAL design wearers
Subjects who have been already wearing any from specified design type of PAL
Progressive Additional Lenses (PAL), pre calibrated and made of polymeric material with anti-reflection coating
Subjects will be wearing three different PAL designs with different geometries of the optical progression.
The other PAL design wearers
Subjects who have been already wearing any from the other design type of PAL
Progressive Additional Lenses (PAL), pre calibrated and made of polymeric material with anti-reflection coating
Subjects will be wearing three different PAL designs with different geometries of the optical progression.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Progressive Additional Lenses (PAL), pre calibrated and made of polymeric material with anti-reflection coating
Subjects will be wearing three different PAL designs with different geometries of the optical progression.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. PAL wearers with 14 mm corridor
3. Age: 45 to 70 years old
4. Best Corrected Monocular visual Acuity (decimal) both at distance and near ≥ 1.0;
5. Normal binocular vision at distance \& near:
* no strabismus on cover test,
* no fixation disparity (Mallett aligning prism of less than 2Δ horizontally or vertically) at near
* stereoacuity of 60" or better at near;
6. New prescription (found at visit #1) is in the range:
* Spherical power: up to +/-6.00;
* Cylindrical power: minus cylinder ≤ 2.5D;
* Addition: 1.50-2.50D;
* Difference in the power (spherical equivalent) between eyes: up to 2.0D
7. Understanding and speaking Italian or English to be able to answer questionnaires
8. Giving a written consent to participate in the study
Exclusion Criteria
2. Prescription found during visit#1 varies from current prescription more than 0.50D in any meridian
3. Wearing Single Vision lenses with accommodative support
4. Double vision or prismatic prescription in current glasses;
5. Known ocular disease including strabismus, any pathology, any eye surgeries that may affect visual acuity
6. Use of systemic or ocular medications that are likely to affect vision
7. Balance problem/vertigo problem
8. Concurrent participation in other vision-related research
45 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hoya Vision Care
INDUSTRY
University of Milano Bicocca
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Silvia Tavazzi
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Optics and Optometry of Milano-Bicocca (COMiB), Department of Materials Science - University of Milano-Bicocca
Milan, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.